Report Detail
Global Osteoarthritis Pain Market Insights, Forecast to 2025
- RnM2799874 |
- 04 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Other
Osteoarthritis, the most common type of arthritis, is a leading cause of disability.
It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age).
The global Osteoarthritis Pain market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Osteoarthritis Pain market based on company, product type, end user and key regions.
This report studies the global market size of Osteoarthritis Pain in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Osteoarthritis Pain in these regions.
This research report categorizes the global Osteoarthritis Pain market by top players/brands, region, type and end user. This report also studies the global Osteoarthritis Pain market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics
Market size by Product
Oral
Non-Oral
Market size by End User
Hospital
Pharmacy
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Osteoarthritis Pain market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Osteoarthritis Pain market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Osteoarthritis Pain companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Osteoarthritis Pain submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Osteoarthritis Pain are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Osteoarthritis Pain market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Osteoarthritis Pain Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Osteoarthritis Pain Market Size Growth Rate by Product
- 1.4.2 Oral
- 1.4.3 Non-Oral
- 1.5 Market by End User
- 1.5.1 Global Osteoarthritis Pain Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Osteoarthritis Pain Market Size
- 2.1.1 Global Osteoarthritis Pain Revenue 2014-2025
- 2.1.2 Global Osteoarthritis Pain Sales 2014-2025
- 2.2 Osteoarthritis Pain Growth Rate by Regions
- 2.2.1 Global Osteoarthritis Pain Sales by Regions
- 2.2.2 Global Osteoarthritis Pain Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Osteoarthritis Pain Sales by Manufacturers
- 3.1.1 Osteoarthritis Pain Sales by Manufacturers
- 3.1.2 Osteoarthritis Pain Sales Market Share by Manufacturers
- 3.1.3 Global Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
- 3.2 Osteoarthritis Pain Revenue by Manufacturers
- 3.2.1 Osteoarthritis Pain Revenue by Manufacturers (2014-2019)
- 3.2.2 Osteoarthritis Pain Revenue Share by Manufacturers (2014-2019)
- 3.3 Osteoarthritis Pain Price by Manufacturers
- 3.4 Osteoarthritis Pain Manufacturing Base Distribution, Product Types
- 3.4.1 Osteoarthritis Pain Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Osteoarthritis Pain Product Type
- 3.4.3 Date of International Manufacturers Enter into Osteoarthritis Pain Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Osteoarthritis Pain Sales by Product
- 4.2 Global Osteoarthritis Pain Revenue by Product
- 4.3 Osteoarthritis Pain Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Osteoarthritis Pain Breakdown Data by End User
6 North America
- 6.1 North America Osteoarthritis Pain by Countries
- 6.1.1 North America Osteoarthritis Pain Sales by Countries
- 6.1.2 North America Osteoarthritis Pain Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Osteoarthritis Pain by Product
- 6.3 North America Osteoarthritis Pain by End User
7 Europe
- 7.1 Europe Osteoarthritis Pain by Countries
- 7.1.1 Europe Osteoarthritis Pain Sales by Countries
- 7.1.2 Europe Osteoarthritis Pain Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Osteoarthritis Pain by Product
- 7.3 Europe Osteoarthritis Pain by End User
8 Asia Pacific
- 8.1 Asia Pacific Osteoarthritis Pain by Countries
- 8.1.1 Asia Pacific Osteoarthritis Pain Sales by Countries
- 8.1.2 Asia Pacific Osteoarthritis Pain Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Osteoarthritis Pain by Product
- 8.3 Asia Pacific Osteoarthritis Pain by End User
9 Central & South America
- 9.1 Central & South America Osteoarthritis Pain by Countries
- 9.1.1 Central & South America Osteoarthritis Pain Sales by Countries
- 9.1.2 Central & South America Osteoarthritis Pain Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Osteoarthritis Pain by Product
- 9.3 Central & South America Osteoarthritis Pain by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Osteoarthritis Pain by Countries
- 10.1.1 Middle East and Africa Osteoarthritis Pain Sales by Countries
- 10.1.2 Middle East and Africa Osteoarthritis Pain Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Osteoarthritis Pain by Product
- 10.3 Middle East and Africa Osteoarthritis Pain by End User
11 Company Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abbott Laboratories Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abbott Laboratories Osteoarthritis Pain Products Offered
- 11.1.5 Abbott Laboratories Recent Development
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Johnson & Johnson Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Johnson & Johnson Osteoarthritis Pain Products Offered
- 11.2.5 Johnson & Johnson Recent Development
- 11.3 Novartis International
- 11.3.1 Novartis International Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis International Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis International Osteoarthritis Pain Products Offered
- 11.3.5 Novartis International Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Osteoarthritis Pain Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 AbbVie
- 11.5.1 AbbVie Company Details
- 11.5.2 Company Business Overview
- 11.5.3 AbbVie Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 AbbVie Osteoarthritis Pain Products Offered
- 11.5.5 AbbVie Recent Development
- 11.6 Abiogen Pharma
- 11.6.1 Abiogen Pharma Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Abiogen Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Abiogen Pharma Osteoarthritis Pain Products Offered
- 11.6.5 Abiogen Pharma Recent Development
- 11.7 Afferent Pharmaceuticals
- 11.7.1 Afferent Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Afferent Pharmaceuticals Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Afferent Pharmaceuticals Osteoarthritis Pain Products Offered
- 11.7.5 Afferent Pharmaceuticals Recent Development
- 11.8 Astellas Pharma
- 11.8.1 Astellas Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Astellas Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Astellas Pharma Osteoarthritis Pain Products Offered
- 11.8.5 Astellas Pharma Recent Development
- 11.9 BioDelivery Sciences International
- 11.9.1 BioDelivery Sciences International Company Details
- 11.9.2 Company Business Overview
- 11.9.3 BioDelivery Sciences International Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 BioDelivery Sciences International Osteoarthritis Pain Products Offered
- 11.9.5 BioDelivery Sciences International Recent Development
- 11.10 Crystal Genomics
- 11.10.1 Crystal Genomics Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Crystal Genomics Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Crystal Genomics Osteoarthritis Pain Products Offered
- 11.10.5 Crystal Genomics Recent Development
- 11.11 Cytori Therapeutics
12 Future Forecast
- 12.1 Osteoarthritis Pain Market Forecast by Regions
- 12.1.1 Global Osteoarthritis Pain Sales Forecast by Regions 2019-2025
- 12.1.2 Global Osteoarthritis Pain Revenue Forecast by Regions 2019-2025
- 12.2 Osteoarthritis Pain Market Forecast by Product
- 12.2.1 Global Osteoarthritis Pain Sales Forecast by Product 2019-2025
- 12.2.2 Global Osteoarthritis Pain Revenue Forecast by Product 2019-2025
- 12.3 Osteoarthritis Pain Market Forecast by End User
- 12.4 North America Osteoarthritis Pain Forecast
- 12.5 Europe Osteoarthritis Pain Forecast
- 12.6 Asia Pacific Osteoarthritis Pain Forecast
- 12.7 Central & South America Osteoarthritis Pain Forecast
- 12.8 Middle East and Africa Osteoarthritis Pain Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Osteoarthritis Pain Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Osteoarthritis Pain . Industry analysis & Market Report on Osteoarthritis Pain is a syndicated market report, published as Global Osteoarthritis Pain Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Osteoarthritis Pain market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
